BackGilead Sciences Overview

Gilead Sciences Cost of Revenue

Cost of Revenue analysis for GILD.

Quarterly Cost of Revenue

$1.45B
50.36% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$5.56B
79% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)